Welcome to Salt Lake City, UT
Our studies
Our Salt Lake City, UT Studies
Our commitment

Our people are passionate about clinical research and advancing the future of medicine. ICON manages an average of 150 studies per year around the world at our various clinical research sites.

We have an experienced team of physicians, clinic and support staff dedicated to making our participants' experience as positive and comfortable as possible. Participant safety is our top priority at all times.

early phase studies per year
Welcome to Salt Lake City

ICON Salt Lake City is conveniently located just minutes from downtown, near St. Mark’s Hospital. With state of the art out-patient facilities and dorm style, semi-private and private rooms, as well as lounges for downtime, we make every effort to make our volunteers’ visit as pleasant as possible. Our 100+ bed research facility is fully equipped to handle the various types of studies we conduct and the physicians and friendly staff are experienced in studies involving healthy volunteers, Alzheimer’s patients, addiction, pain, dentistry, psychiatry, neurology, pediatric research and infectious disease. For more information or to schedule a tour, please call our staff at 1-801-269-82001-801-269-8200, or click here to send us a note.

In Salt Lake City, we’ve conducted a wide range of clinical trials including:
  • Adult & Pediatric ADHD

  • Adult & Pediatric Tourette’s
  • Syndrome
  • Alzheimer’s Disease & MCI
  • Anxiety
  • Bipolar
  • Bunionectomy
  • Dental
  • Depression
  • Derm
  • Diabetes
  • Gout
  • Healthy Normal Adults, Elderly & Pediatric
  • Hyperlipidemia ( High Cholesterol)
  • Hypertension ( High Blood Pressure)
  • Insomnia
  • Migraine
  • Multiple Sclerosis
  • Obesity
  • Opiate Addiction
  • Osteoarthritis
  • Osteoporosis
  • Pain
  • Pediatric Autism
  • QTc
  • Recreational Drug Users (Cocaine, Opioids, Pain Pills, Stimulants, etc.)
  • Restless Leg Syndrome
  • Sleep Disorders
  • Smoking Cessation
  • Vaccines
  • Women’s Health

Get in Touch
ICON 1255 East 3900 South Salt Lake City, UT 84124
(801) 269-8200 (801) 269-8200
Our team
Dr. Shawn Searle, MD, CPI

Shawn Searle, MD, joined ICON as a Principal Investigator in August 2013. He has been Principal Investigator for over 88 clinical trials with ICON. Dr. Searle is Board Certified in Family Medicine and has additional training in Dermatology. Prior to making the switch to full-time pharmaceutical research, his clinical background was working in Emergency/Urgent Care medicine and Dermatology.

Before going to medical school, Dr. Searle attended Brigham Young University, majoring in Psychology with a pre-medicine emphasis. His medical training was at the University of Texas Health Science Center in San Antonio, TX. While completing his Medical Doctor Degree, he also participated in research with the orthopedic department examining the calcification processes of synovial and connective tissues. Dr. Searle then went to Phoenix, Arizona and completed his residency in Family Medicine at Banner Good Samaritan Hospital.

Dr. Searle began pharmaceutical research at Dedicated Phase One in Phoenix. He was Medical Director and Principal Investigator, and also on the company’s Board of Directors, for the first two years of the company’s existence and Dr. Searle helped it grow to be one of the premiere early-phase, patient-population sites in the Southwest. Study areas included Diabetes, Lupus, Alzheimer’s disease, Rheumatoid Arthritis, Multiple Sclerosis, Bipolar disorder and Healthy/Normal populations.

After a short time back in clinical medicine, Dr. Searle returned to early-phase research at Comprehensive Clinical Development in Tacoma, Washington. As Principal Investigator, his studies included First-In-Human trials as well as Oncology, Dermatology, Chronic Hepatitis C and Vaccine trials. He also certified and became licensed as an Authorized User of Radioactivity for the State of Washington. With this, he was the principal or sub-investigator for numerous trials examining the ADME (Absorption, Distribution, Metabolism and Excretion) and Pharmacokinetics of C 14 -labelled compounds in healthy/normal and Oncology patient populations.

Ahad Sabet, MD, FACP, CPI

Dr. Ahad Sabet began his professional career at University of Illinois Urbana-Champaign. During his undergraduate training he earned a Bachelor of Science in Cell and Structural Biology as well as a minor in chemistry. This undergraduate curriculum had a strong emphasis on molecular biology and biomedical research.

He completed his first two years of medical school at the Universidad Autonoma de Guadalajara; where he acquired a solid foundation in clinical medicine and fluency in Spanish. He continued his education in Puerto Rico, and ultimately obtained his Medical Degree from Ponce School of Medicine.

After medical school, Dr. Sabet returned to the United States for continued training in Phoenix, Arizona. There he completed a dual residency in Internal Medicine and Pediatrics from Maricopa Medical Center in affiliation with Phoenix Children’s Hospital. He went on to become Chief Resident in Internal Medicine at Maricopa Medical Center and soon thereafter obtained his board certifications in both Internal Medicine and Pediatrics.

Following residency Dr. Sabet embarked on a series of travel medicine assignments. He spent a year working as a consultant physician in New Zealand; after which he returned to work as an Internal Medicine hospitalist in several areas across the western United States. Ultimately, he settled in Salt Lake City and after more than ten years of practicing and teaching clinical medicine, he found his way back to research.

Dr. Sabet joined ICON as a Sub-Investigator in September of 2015. His broad clinical experience has been well employed on trials across multiple disciplines including: pain/therapeutics, anesthesiology, immunology, lipid/metabolism, viral hepatitis, Alzheimer’s disease, and depression. His research experience includes First-In-Human, HAL, BA, BE, VRH, and PK/PD trials in addition to multicenter phase II and III studies. He has ascended through the research ranks and currently serves as Principal investigator on several early and late phase clinical trials.

Matt Johnston, MD, MMM, CPI

Dr. Matt Johnston, MD is Board Certified by the American Board of Family Medicine. His emphasis prior to entering clinical research was in clinical primary care and population care.

Dr. Johnston attended undergraduate school at Brigham Young University, majoring in Chemistry with a minor in English Literature. Proceeding to Baylor College of Medicine in Houston, TX for medical training receiving his Medical Doctor Degree. While in medical school he published research in the Hematology Department relating to Hemoglobin C Hemoglobinopathy.

Dr. Johnston continued to the University of Oklahoma, with residency study in Family Medicine. His final year he served as Chief Resident for the program and participated in education and training of students and residents. Dr. Johnston later served as an adjunct professor with the University of Oklahoma teaching medical students in Family Medicine. Completing a master’s degree in Medical Management from Tulane University, with an emphasis on Population Health and Medical Economics allowed Dr. Johnston to serve on multiple hospital administrative boards.

• The medical leadership board for the Cherokee Nation Health System
• The Inaugural Board of Directors for the Tulsa County Health Improvement Organization
• Pharmacy Therapeutic Board for an insurance company
• The Medical Department Chairman at a Regional Hospital
• Rural Health Liaison for the Oklahoma Healthy Heart Project

Dr. Johnston joined ICON as a full-time Clinical Research Physician in September of 2017. Serving as a Sub-Investigator and Principal Investigator on studies across multiple disciplines. Studies include: pain/therapeutics, Alzheimer’s disease, depression, immunology, oncology, liver disease, and lipid metabolism. These trials involve first-in-human testing, BA/BE studies, PK/PD trials, drug-drug Interaction, HAL, and multicenter phase II and phase III outpatient studies.

Upcoming events

There are no upcoming events for now.

Actual study participant
Lenexa, KS
“Enjoyed my stay and the staff are wonderful.”
Actual study participant
Lenexa, KS
“All employees were extremely courteous and helpful.”
Actual study participant
Lenexa, KS
“Wonderful staff. I am a newbie, but friendly and helpful staff eased the apprehensions.”
Actual study participant
Lenexa, KS
“ICON has an excellent staff from recruiters to medical staff, and a nice, clean facility.”
Actual study participant
Lenexa, KS
“It looks to me like ICON staff is courteous and very knowledgeable of the proceedings and well-being of every participant.”
Actual study participant
Lenexa, KS
“The staff at ICON is wonderful. Very professional and friendly.”
Actual study participant
Lenexa, KS
“Staff is friendly and professional.”
Frequently asked questions
Will I get paid for participating in a clinical study?

While participation in a clinical study is voluntary, you may be paid for your time and travel. Compensation is based on the length of the study, the number of overnight stays in our clinic and the number of out-patient visits you attend. You may also be compensated for some procedures depending upon the study. All payments we make for study participation have been approved by an Independent Review Board (IRB). The method and frequency of payment will be described in detail in the Informed Consent Form (ICF).

What if I’d like to refer a friend or family member for a study?

Even if you don’t qualify for a particular study, you may be able to refer a friend or family member. If approved by an Independent Review Board (IRB), ICON may be able to provide you a referral bonus of up to $500 for each qualified study participant that you refer. To qualify for the payment, the person you refer must:

• Be a first-time volunteer

• Mention your name when applying over the phone

• Fully participate in the study

All payments from ICON must be approved by an IRB before any payment may be made to you. Please contact us for more information.